Ads

 

Ads

 

Ads

 

World Top 100 HealthCare Products Companies List by Market Cap in January 2024

World Top 100 HealthCare Products Companies List by Market Cap in January 2024, World Biggest 100 HealthCare Products Companies by Market Cap, World Largest 100 HealthCare Products Companies in the World by market cap as pf Jan-05-2024.

Metatag Title
World Largest HealthCare Products Companies in 2024
Metatag Abstract
World Top HealthCare Products Companies by Market Cap in 2024, World Largest HealthCare Products Companies by Market Cap in 2024.
  1. Ningbo Menovo Pharmaceutical

    World Rank (Jan-05-2024)
    11,911
    Market Cap (Jan-05-2024)
    0.561 Billion USD
    World Rank (Jul-30-2023)
    12,434
    Market Cap (Jul-30-2023)
    0.525 Billion USD
    World Rank (Dec-25-2022)
    9,274
    Market Cap (Dec-25-2022)
    0.848 Billion USD
    World Rank (Jan-07-2022)
    10,697
    Market Cap (Jan-07-2022)
    0.80 Billion USD
    Headquarters Country
  2. PetIQ Inc.

    World Rank (Jan-05-2024)
    11,950
    Market Cap (Jan-05-2024)
    0.558 Billion USD
    World Rank (Jul-30-2023)
    13,043
    Market Cap (Jul-30-2023)
    0.477 Billion USD
    World Rank (Dec-25-2022)
    16,363
    Market Cap (Dec-25-2022)
    0.272 Billion USD
    World Rank (Jan-07-2022)
    12,394
    Market Cap (Jan-07-2022)
    0.59 Billion USD
    Annual Revenue in USD
    932 Million USD
    Annual Net Income in USD
    -15 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Animals healthcare company with headquarters is in Idaho, USA
  3. Aarti Drugs

    World Rank (Jan-05-2024)
    11,975
    Market Cap (Jan-05-2024)
    0.555 Billion USD
    World Rank (Jul-30-2023)
    11,040
    Market Cap (Jul-30-2023)
    0.657 Billion USD
    World Rank (Dec-25-2022)
    12,413
    Market Cap (Dec-25-2022)
    0.499 Billion USD
    World Rank (Jan-07-2022)
    11,826
    Market Cap (Jan-07-2022)
    0.65 Billion USD
    Annual Revenue in USD
    311 Million USD
    Annual Net Income in USD
    26 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Stock Category
  4. Pulse Biosciences

    World Rank (Jan-05-2024)
    11,984
    Market Cap (Jan-05-2024)
    0.555 Billion USD
    World Rank (Jul-30-2023)
    13,911
    Market Cap (Jul-30-2023)
    0.416 Billion USD
    World Rank (Dec-25-2022)
    21,978
    Market Cap (Dec-25-2022)
    0.094 Billion USD
    World Rank (Jan-07-2022)
    14,855
    Market Cap (Jan-07-2022)
    0.40 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -50 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Company Profile
    Pulse Biosciences is a Novel Bioelectric Medicine company committed to health innovation that has the potential to improve and extend the lives of patients. It have 112 issued patents globally owned and licensed. The company annual revenue is 343.5 million USD and 82 employees as on 2020. The headquarters is in USA.
  5. Chongqing Lummy Pharmaceutical

    World Rank (Jan-05-2024)
    12,059
    Market Cap (Jan-05-2024)
    0.547 Billion USD
    World Rank (Jul-30-2023)
    12,454
    Market Cap (Jul-30-2023)
    0.524 Billion USD
    World Rank (Dec-25-2022)
    11,343
    Market Cap (Dec-25-2022)
    0.592 Billion USD
    World Rank (Jan-07-2022)
    8,945
    Market Cap (Jan-07-2022)
    1.09 Billion USD
    Headquarters Country
  6. Clinuvel Pharmaceuticals

    World Rank (Jan-05-2024)
    12,152
    Market Cap (Jan-05-2024)
    0.538 Billion USD
    World Rank (Jul-30-2023)
    11,549
    Market Cap (Jul-30-2023)
    0.603 Billion USD
    World Rank (Dec-25-2022)
    10,246
    Market Cap (Dec-25-2022)
    0.712 Billion USD
    World Rank (Jan-07-2022)
    9,638
    Market Cap (Jan-07-2022)
    0.96 Billion USD
    Annual Revenue in USD
    45 Million USD
    Annual Net Income in USD
    14 Million USD
    Annual Results for Period Ending
    Jun-2022 ending year
    Headquarters Country
    Company Profile
    Clinuvel Pharmaceuticals is a Biopharmaceutical company. The company focused on developing and commercializing treatments for patients with genetic, metabolic and life threatening disorders as well as healthcare solutions for the general population. The headquarters is in Australia.
  7. Ocular Therapeutix

    World Rank (Jan-05-2024)
    12,314
    Market Cap (Jan-05-2024)
    0.523 Billion USD
    World Rank (Jul-30-2023)
    14,969
    Market Cap (Jul-30-2023)
    0.350 Billion USD
    World Rank (Dec-25-2022)
    17,875
    Market Cap (Dec-25-2022)
    0.206 Billion USD
    World Rank (Jan-07-2022)
    13,549
    Market Cap (Jan-07-2022)
    0.49 Billion USD
    Annual Revenue in USD
    43 Million USD
    Annual Net Income in USD
    -6 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Ocular Therapeutix is a Biopharmaceutical Platform company focused on the formulation, development and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bioresorbable hydrogel based formulation technology. The company annual revenue is 12.3 million USD and 167 employees as on 2019. The headquarters is in USA.
  8. Phathom Pharmaceuticals

    World Rank (Jan-05-2024)
    12,344
    Market Cap (Jan-05-2024)
    0.521 Billion USD
    World Rank (Jul-30-2023)
    9,683
    Market Cap (Jul-30-2023)
    0.835 Billion USD
    World Rank (Dec-25-2022)
    12,820
    Market Cap (Dec-25-2022)
    0.470 Billion USD
    World Rank (Jan-07-2022)
    13,041
    Market Cap (Jan-07-2022)
    0.53 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -172 Million USD
    Annual Net Income in USD
    -197 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Phathom Pharmaceuticals is a Clinical Stage Biopharmaceutical company committed to transforming the treatment landscape and improving the lives of patients suffering from acid related gastrointestinal (GI) disorders. The company annual revenue is approximately 74.5 million USD, total assets is 263.9 million USD and 16 employees as on 2019. The headquarters is in USA.

Share

Ads